Overview
Synovitis and tenosynovitis of multiple joints involve inflammation of the synovial membranes and tendon sheaths across several joints, often presenting with pain, swelling, and limited mobility. These conditions can arise from various etiologies including autoimmune disorders, crystal arthropathies, or repetitive strain injuries 1.Diagnosis
Clinical Presentation: Pain, swelling, warmth, and tenderness over affected joints and tendons 1.
Imaging: Ultrasound or MRI can help visualize synovial thickening and effusions 1.
Laboratory Tests: Elevated inflammatory markers (ESR, CRP) may be present, though not specific 1.
Differential Diagnosis: Rule out other inflammatory arthropathies, crystal arthropathies, and infectious causes 1.Management
First-Line Treatments:
- Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): For pain and inflammation management 1.
- Rest and Immobilization: To reduce joint stress and promote healing 1.
Adjunctive Treatments:
- Corticosteroids: Intra-articular or systemic for severe inflammation 1.
- Physical Therapy: To maintain joint mobility and strength 1.
- Pharmacogenomic Testing: Consider in complex cases with polypharmacy to minimize adverse drug events, particularly when managing medications like statins and anticoagulants 1.Special Populations
Elderly: Increased risk of polypharmacy and comorbidities necessitates careful medication management and consideration of pharmacogenomic testing to prevent adverse drug events 1.Key Recommendations
Utilize pharmacogenomic testing in elderly patients with multiple comorbidities and polypharmacy to optimize medication safety and efficacy (Evidence: Expert opinion) 1.
Employ NSAIDs as first-line pharmacological treatment for managing pain and inflammation in synovitis and tenosynovitis (Evidence: Moderate) 1.
Consider corticosteroid interventions for severe cases to effectively reduce inflammation and alleviate symptoms (Evidence: Moderate) 1.References
1 Jessop JP, Russell J, DeJesus A, Bardolia C, Hanna A, Turgeon J et al.. Pharmacogenetic Testing in a 70-Year-Old Woman with Polypharmacy and Multiple Comorbidities: A Case Report. The American journal of case reports 2023. link